10 Comments
User's avatar
โญ  Return to thread
Jessica Rose's avatar

not really. they designed something really harmful to human physiology.

Expand full comment
The BarefootHealer's avatar

๐Ÿ˜‰ one could almost conclude that they couldn't have stuffed it up more if they tried! It's almost "methodical" in how "badly" these things were designed to %$#@ up the mitochondria.๐Ÿคจ๐Ÿค๐Ÿ˜‰๐Ÿคฆโ€โ™€๏ธ๐Ÿคฆโ€โ™€๏ธ

Expand full comment
Zefram's avatar

Looks pretty deliberate and diabolical to me.

Expand full comment
Jaime Jessop's avatar

I remember Prof Angus Dalgleish saying that the spike protein was something like 80% homologous with human proteins, though I can't be sure of the exact figure, it was very significant. Then they injected it into billions of people to provoke a 'targeted' immune response . . . . . big target!

Expand full comment
Paul Traynor BSc's avatar

So, if there was a novel therapeutic that interfered with the bodyโ€™s cellsโ€™ ability to produce p53 and make the BRCA pathway work defending our genome - you would think that would be important, wouldnโ€™t you? Well I guess it depends on who is funding the therapeutic and whether they care two hoots whether you (or your mother, wife or daughter) get cancer.

Expand full comment
Gary F's avatar

I wonder how "Safe and Effective" the new anti-cancer Mrna vaxx will be? Maybe it will add a hemorrhagic component to the fun list of side-effects we already enjoy.

Expand full comment
Dennis Rodgers's avatar

Let's recall that in all the years since injectable mRNA was conjured, it's record of failure in clinical trials is unblemished. AND the damage is heritable, showing up worse in the third and fourth generation, and probably beyond. That this was ever administer to a single person is simply unconscionable.

Expand full comment
Sez77's avatar

"Well I guess it depends on who is funding the therapeutic".

And what their true goal is.

Expand full comment
Paul Traynor BSc's avatar

inactivation is considered to be one of the most common molecular mechanisms behind the dysfunction of p53. Extensive mutation search revealed that more than half of human cancers carry loss of function mutations of p53. Among them, 95% of mutations were detectable within the genomic region (exons 5โ€“8) encoding the DNA-binding domain.

Expand full comment
Paul Traynor BSc's avatar

So, if there was a novel therapeutic that interfered with the bodyโ€™s cellsโ€™ ability to produce p53 and make the BRCA pathway work defending our genome - you would think that would be important, wouldnโ€™t you? Well I guess it depends on who is funding the therapeutic and whether they care two hoots whether you (or your mother, wife or daughter) get cancer.

Expand full comment